Please enable JavaScript to continue using this application.

Compare $DWTX vs $LITS | Chartloom

Compare

$DWTX vs $LITS

Dogwood Therapeutics Inc · Lite Strategy Inc

DWTX

Dogwood Therapeutics Inc

LITS

Lite Strategy Inc

Compare $DWTX vs $LITS

Comparing Dogwood Therapeutics Inc and Lite Strategy Inc

DWTXDogwood Therapeutics Inc

LITSLite Strategy Inc

DWTXDogwood Therapeutics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.0%

52W performance

-78.1%

FCF yield

-32.1%

LITSLite Strategy Inc

Market cap

$43M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-17.5%

52W performance

-49.2%

FCF yield

-21.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

DWTX

LITS

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

LITS

Lite Strategy Inc

Market Cap

DWTX$47M

LITS$43M

Enterprise Value

DWTX$37M

LITS$38M

Price

DWTX$1.40

LITS$1.27

P/E Ratio

DWTXN/A

LITSN/A

P/S Ratio

DWTX0.00x

LITS0.40x

EV/Sales

DWTX0.00x

LITS0.00x

EV/EBITDA

DWTX0.00x

LITS0.00x

P/B Ratio

DWTX0.73x

LITS1.01x

P/FCF Ratio

DWTXN/A

LITSN/A

EV/FCF

DWTX-2.48x

LITS-4.11x

PEG Ratio

DWTXN/A

LITSN/A

Forward P/E (NTM)

DWTXN/A

LITSN/A

Forward P/S (NTM)

DWTXN/A

LITSN/A

Revenue (TTM)

DWTX$0

LITS$0

Revenue Growth (YoY)

DWTXN/A

LITSN/A

Forward Rev Growth

DWTX613.9%

LITS0.0%

Gross Margin (TTM)

DWTX0.0%

LITS100.0%

Operating Margin (TTM)

DWTX0.0%

LITS34.9%

EBITDA Margin (TTM)

DWTX0.0%

LITS0.0%

Net Margin (TTM)

DWTX0.0%

LITS39.0%

FCF Margin (TTM)

DWTXN/A

LITSN/A

Net Income (TTM)

DWTX$-25M

LITS$-34M

FCF (TTM)

DWTX$-15M

LITS$-9M

EPS (TTM)

DWTX$0.00

LITS$0.00

ROE (TTM)

DWTX-3591.0%

LITS-6886.0%

ROA (TTM)

DWTX-3028.0%

LITS-6748.0%

ROIC (TTM)

DWTX-3591.0%

LITS-6886.0%

Cash

DWTX$10M

LITS$6M

Debt

DWTX$0

LITS$0

Net Cash/Debt

DWTX$10M

LITS$6M

Current Ratio (TTM)

DWTX3.89x

LITS5.74x

Quick Ratio (TTM)

DWTX3.41x

LITS5.34x

Debt/Equity (TTM)

DWTX0.00x

LITS0.00x

Debt/Assets (TTM)

DWTX0.0%

LITS0.0%

Interest Coverage (TTM)

DWTXN/A

LITSN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

LITS0.00x

Beta

DWTX2.14

LITS0.06

52W Performance

DWTX-78.1%

LITS-49.2%

YTD Performance

DWTX-67.0%

LITS-17.5%

% from 52W High

DWTX-80.1%

LITS-57.2%

% from 52W Low

DWTX9.4%

LITS84.4%

Asset Turnover (TTM)

DWTX0.00x

LITS0.84x

FCF Yield (TTM)

DWTX-32.1%

LITS-21.1%

Earnings Yield (TTM)

DWTX-52.1%

LITS-79.7%

Dividend Yield (TTM)

DWTXN/A

LITSN/A

Rule of 40

DWTX0.0

LITS0.0

EV/GP/RG

DWTXN/A

LITSN/A

Ticker research

View DWTX research View LITS research

Metric	DWTX Dogwood Therapeutics Inc	LITS Lite Strategy Inc
Market & Valuation
Market Cap	$47M	$43M
Enterprise Value	$37M	$38M
Price	$1.40	$1.27
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.40x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-4.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	34.9%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	39.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-25M	$-34M
FCF (TTM)	$-15M	$-9M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-3591.0%	-6886.0%
ROA (TTM)	-3028.0%	-6748.0%
ROIC (TTM)	-3591.0%	-6886.0%
Financial Health
Cash	$10M	$6M
Debt	$0	$0
Net Cash/Debt	$10M	$6M
Current Ratio (TTM)	3.89x	5.74x
Quick Ratio (TTM)	3.41x	5.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	0.06
52W Performance	-78.1%	-49.2%
YTD Performance	-67.0%	-17.5%
% from 52W High	-80.1%	-57.2%
% from 52W Low	9.4%	84.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.84x
FCF Yield (TTM)	-32.1%	-21.1%
Earnings Yield (TTM)	-52.1%	-79.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View LITS research

Valuation

P/S Ratio

DWTX

0.00x

LITS

0.40x

EV/FCF

LITS

-4.11x

DWTX

-2.48x

Growth & revenue

Forward Revenue Growth

DWTX

613.9%

LITS

0.0%

Profitability & performance

Gross Margin

LITS

100.0%

DWTX

0.0%

ROE

DWTX

-3591.0%

LITS

-6886.0%

FCF Yield %

LITS

-21.1%

DWTX

-32.1%

52-Week Performance

LITS

-49.2%

DWTX

-78.1%

Detailed metrics comparison

DWTX

Dogwood Therapeutics Inc

LITS

Lite Strategy Inc

Market Cap

DWTX$47M

LITS$43M

Enterprise Value

DWTX$37M

LITS$38M

Price

DWTX$1.40

LITS$1.27

P/E Ratio

DWTXN/A

LITSN/A

P/S Ratio

DWTX0.00x

LITS0.40x

EV/Sales

DWTX0.00x

LITS0.00x

EV/EBITDA

DWTX0.00x

LITS0.00x

P/B Ratio

DWTX0.73x

LITS1.01x

P/FCF Ratio

DWTXN/A

LITSN/A

EV/FCF

DWTX-2.48x

LITS-4.11x

PEG Ratio

DWTXN/A

LITSN/A

Forward P/E (NTM)

DWTXN/A

LITSN/A

Forward P/S (NTM)

DWTXN/A

LITSN/A

Revenue (TTM)

DWTX$0

LITS$0

Revenue Growth (YoY)

DWTXN/A

LITSN/A

Forward Rev Growth

DWTX613.9%

LITS0.0%

Gross Margin (TTM)

DWTX0.0%

LITS100.0%

Operating Margin (TTM)

DWTX0.0%

LITS34.9%

EBITDA Margin (TTM)

DWTX0.0%

LITS0.0%

Net Margin (TTM)

DWTX0.0%

LITS39.0%

FCF Margin (TTM)

DWTXN/A

LITSN/A

Net Income (TTM)

DWTX$-25M

LITS$-34M

FCF (TTM)

DWTX$-15M

LITS$-9M

EPS (TTM)

DWTX$0.00

LITS$0.00

ROE (TTM)

DWTX-3591.0%

LITS-6886.0%

ROA (TTM)

DWTX-3028.0%

LITS-6748.0%

ROIC (TTM)

DWTX-3591.0%

LITS-6886.0%

Cash

DWTX$10M

LITS$6M

Debt

DWTX$0

LITS$0

Net Cash/Debt

DWTX$10M

LITS$6M

Current Ratio (TTM)

DWTX3.89x

LITS5.74x

Quick Ratio (TTM)

DWTX3.41x

LITS5.34x

Debt/Equity (TTM)

DWTX0.00x

LITS0.00x

Debt/Assets (TTM)

DWTX0.0%

LITS0.0%

Interest Coverage (TTM)

DWTXN/A

LITSN/A

Net Debt/EBITDA (TTM)

DWTX0.00x

LITS0.00x

Beta

DWTX2.14

LITS0.06

52W Performance

DWTX-78.1%

LITS-49.2%

YTD Performance

DWTX-67.0%

LITS-17.5%

% from 52W High

DWTX-80.1%

LITS-57.2%

% from 52W Low

DWTX9.4%

LITS84.4%

Asset Turnover (TTM)

DWTX0.00x

LITS0.84x

FCF Yield (TTM)

DWTX-32.1%

LITS-21.1%

Earnings Yield (TTM)

DWTX-52.1%

LITS-79.7%

Dividend Yield (TTM)

DWTXN/A

LITSN/A

Rule of 40

DWTX0.0

LITS0.0

EV/GP/RG

DWTXN/A

LITSN/A

Ticker research

View DWTX research View LITS research

Metric	DWTX Dogwood Therapeutics Inc	LITS Lite Strategy Inc
Market & Valuation
Market Cap	$47M	$43M
Enterprise Value	$37M	$38M
Price	$1.40	$1.27
P/E Ratio	N/A	N/A
P/S Ratio	0.00x	0.40x
EV/Sales	0.00x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	0.73x	1.01x
P/FCF Ratio	N/A	N/A
EV/FCF	-2.48x	-4.11x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$0	$0
Revenue Growth (YoY)	N/A	N/A
Forward Rev Growth	613.9%	0.0%
Profitability
Gross Margin (TTM)	0.0%	100.0%
Operating Margin (TTM)	0.0%	34.9%
EBITDA Margin (TTM)	0.0%	0.0%
Net Margin (TTM)	0.0%	39.0%
FCF Margin (TTM)	N/A	N/A
Net Income (TTM)	$-25M	$-34M
FCF (TTM)	$-15M	$-9M
EPS (TTM)	$0.00	$0.00
ROE (TTM)	-3591.0%	-6886.0%
ROA (TTM)	-3028.0%	-6748.0%
ROIC (TTM)	-3591.0%	-6886.0%
Financial Health
Cash	$10M	$6M
Debt	$0	$0
Net Cash/Debt	$10M	$6M
Current Ratio (TTM)	3.89x	5.74x
Quick Ratio (TTM)	3.41x	5.34x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.14	0.06
52W Performance	-78.1%	-49.2%
YTD Performance	-67.0%	-17.5%
% from 52W High	-80.1%	-57.2%
% from 52W Low	9.4%	84.4%
Efficiency & Yields
Asset Turnover (TTM)	0.00x	0.84x
FCF Yield (TTM)	-32.1%	-21.1%
Earnings Yield (TTM)	-52.1%	-79.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	0.0	0.0
EV/GP/RG	N/A	N/A
Ticker research	View DWTX research	View LITS research